Corporate Member Update: Incyte-FDA Approved – MONJUVI®

Corporate Member Update: Incyte-FDA Approved – MONJUVI®

MONJUVI®
August, 2020

On behalf of MorphoSys US Inc. and Incyte Corporation, we'd like to announce the approval of MONJUVI® (tafasitamabcxix)for injection, for intravenous use by the U.S. Food and Drug Administration (FDA) on 07/31/2020.

Click here to learn more about this new medication.

 

 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members